行情

CSII

CSII

心血管系统公司
NASDAQ

实时行情|Nasdaq Last Sale

33.96
-0.63
-1.82%
盘后: 33.96 0 0.00% 16:44 03/27 EDT
开盘
33.57
昨收
34.59
最高
34.84
最低
32.17
成交量
25.96万
成交额
--
52周最高
55.22
52周最低
26.00
市值
11.97亿
市盈率(TTM)
-163.8996
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CSII价格均价为54.60,最高价位64.00,最低价为42.00。

EPS

CSII 新闻

更多
  • 李显龙:抗疫斗争正在升级 旅游、航空业几乎已死
  • 新浪美股 · 1小时前
  • 因“沟通有误”错过欧盟集中采购 英国面临呼吸机严重短缺
  • 新浪财经 · 3小时前
  • 疫情带来“超级推迟日”:美国多州将在6月扎堆举行大选初选
  • 澎湃新闻 · 4小时前
  • “危机预言家”拉詹呼吁美国取消对华关税以帮助抗疫
  • 第一财经 · 5小时前

所属板块

医疗设备、用品及经销
-1.60%
医疗设备和用品
-1.86%

热门股票

代码
价格
涨跌幅

CSII 简况

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.
展开

微牛提供Cardiovascular Systems Inc(NASDAQ-CSII)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CSII股票新闻,以帮助您做出投资决策。